In the present study, we investigate TMEM106A gene expression and promoter methylation in human HCC cell lines in order to assess the relationship between promoter methylation and transcriptional inactivation of TMEM106A. The gene discussed is TMEM106A; the disease is hepatocellular carcinoma.